The disappointing result means that AZ will be unable to follow in the footsteps of GSK, whose IL-5 inhibitor Nucala ...
The likelihood for mortality during hospitalization was increased among those with COPD or asthma vs. asthma-COPD overlap ...
Adherium Limited (ASX: ADR), a global leader in connected respiratory health solutions, has today announced preliminary results from the groundbreaking iCARE study, a real-world study conducted in ...
Lucknow: A simple blood test every three months could save the lives of Chronic Obstructive Pulmonary Disease (COPD) patients ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. “Clinicians can take away from our article that COPD is ...
Stocktwits on MSN
AstraZeneca Says Asthma Drug Failed Trial In Smoker’s Disease
AstraZeneca (AZN) announced on Wednesday that its late-stage trial of Fasenra in patients with chronic obstructive pulmonary ...
In-hospital deaths for heart attacks, heart failure, stroke and pneumonia have all decreased, according to the latest reports for 2022 and 2023.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback